Showing results (51-60 of 242) with videos related to
Sort By:
Pageof 25
European Journal of Gastroenterology & Hepatology|April 21, 2004
A case of Gardner syndrome with a mutation at codon 1556 of APC: a suggested case of genotype-phenotype correlation in dental abnormalityTakatomi Oku, Tetsuji Takayama, Yasuhiro Sato, et al.Internal Medicine (Tokyo, Japan)|April 19, 2008
Successful treatment of chronic myeloproliferative disease-unclassifiable (CMPD-U) with no chromosomal abnormalities by imatinib mesylateSatoshi Iyama, Takuya Matsunaga, Tsutomu Sato, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 7, 2024
Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practiceTetsu Tomonari, Joji Tani, Yasushi Sato, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2007
[Fifth-line chemotherapy for metastatic gastric cancer--a case responding to modified FOLFOX 6]Tamotsu Sagawa, Yasushi Sato, Tetsuji Takayama, et al.Clinical Journal of Gastroenterology|August 26, 2023
Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case seriesReiko Yokoyama, Yasushi Sato, Fumika Nakamura, et al.Journal of Medical Ultrasonics (2001)|June 10, 2016
A novel treatment for early gastrointestinal carcinoma by ultrasonic endoscopic mucosal strippingHidetoshi Ohta, Naoaki Shintani, Koshi Fujikawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 2, 2007
[Anaphylactic reaction to oxaliplatin--a case of colon cancer]Tamotsu Sagawa, Yasushi Sato, Seiichiro Abe, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Sorafenib as second-line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinomaTetsu Tomonari, Yasushi Sato, Hironori Tanaka, et al.Clinical Journal of Gastroenterology|March 1, 2023
A case of complete response with rechallenge-lenvatinib plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma refractory to multiple molecular-targeted agent treatmentsTetsu Tomonari, Hironori Tanaka, Takahiro Tanaka, et al.Journal of Gastroenterology|November 22, 2023
Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathwayTomoyuki Kawaguchi, Koichi Okamoto, Shota Fujimoto, et al.Pageof 25